EMA Authorised: Entecavir Accord (Entecavir) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Entecavir Accord (entecavir) for chronic hepatitis B, confirming a generic entecavir product is now approved in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Entecavir Accord (Entecavir)

Snippet

Status: Authorised. Therapeutic area: Hepatitis B, Chronic. MAH: Accord Healthcare S.L.U.. Decision date: 01/07/2022